We share insights from completed and ongoing clinical trial results here
Clinical Trials
State of the Art Skin Imaging Analysis
In partnership with EVELAB, MESCH uses its skin imaging analysis technology and artificial intelligence to validate the transformative effects of EXOGLO’s formula. This data-driven approach ensures that our products deliver results you can trust, with the accuracy and precision that only AI can provide.
The EVELAB system assesses over 35 skin conditions, utilizing algorithms trained on a database of over 10 million labeled images, with scoring guided by dermatologists, environmental medicine specialists, and microbiome researchers. This extensive dataset ensures precise and reliable measurement of skin improvements, such as brightness and texture, demonstrating EXOGLO’s efficacy with data-driven precision.
PERIORBITAL FINE LINES
Our formulation strengthens the skin’s barrier and delivers sustained hydration to reduce transepidermal water loss. It also helps increase skin renewal resulting in visibly smoother skin with reduced appearance of fine lines
MEDIAL MALAR
Enriched with human-derived exosomes, our advanced formulation supports cellular communication and dermal matrix integrity. Over time, restoring bounce and firmness, visibly lifting skin and reducing signs of fatigue and laxity
PIGMENTARY SPOTS
The inclusion of Ascorbyl Tetraisopalmitate, a stable and oil-soluble form of Vitamin C, helps diminish dullness by boosting skin radiance and clarity. Enhanced moisture levels contribute to a visibly more luminous and even skin tone
FACIAL SKIN HYDRATION
Powered by a lipid delivery complex, our formulation mimics the skin’s natural composition, reinforcing the barrier, trapping hydration and maintaining optimal moisture levels for up to 24 hours, resulting in a plump and dewy complexion